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ABSTRACT 
 
Staphylococcus aureus, the most virulent Staphylococcus species, is also the prevalent pathogen isolated 
from hospitalized patients and the second most common from patients in outpatient settings. In general, 
bacteria have the genetic ability to transmit and acquire resistance to drugs, which are utilized as therapeutic 
agents. Related studies of antimicrobial activity indicate that crude extracts containing flavonoids, 
triterpenes and steroids have showed significative activity against several Staphylococcus aureus strains. 
Combination effects between flavonoids and antibiotics also have been reported. The aim of the present 
work was to investigate in vitro synergism between several  chalcones substituted in combination with 
oxacillin, an antibiotic used conventionally against S. aureus  ATCC 43 300 that is resistant to meticillin, 
using the kinetic turbidimetric method developed earlier. The results were satisfactory for all assayed 
combinations and in accordance with the mechanism of bacteriostatic inhibition previously proposed, except 
for 2´,4´-dihydroxy-3´-methoxychalcone – oxacillin. The best combination was 2´,3´-dihydroxychalcone - 
oxacillin (MIC: 11.2 µg/mL). Further investigations are needed to characterize the interaction mechanism 
with antibiotics. Thus, chalcones - oxacillin combination could lead to the development of new antibiotics 
against  methicillin resistant S. aureus  infection. 
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INTRODUCTION 
 
Staphylococcus aureus, the most virulent Staphylococcus 
species, is also the prevalent pathogen isolated from 
hospitalized patients and the second most common from 
patients in outpatient settings (14). Humans are a natural 
reservoir of S. aureus. The emergence of a pathogen 
community depends on its ability to survive in different 
environments and to interact successfully with the host.  These 
microorganisms cause a wide range of syndromes, from skin 
and soft tissue minor infection up to life-threatening 
pneumonia and toxemy such as toxic shock syndrome. Both 
methicillin-sensitive and methicillin-resistant strains isolates 
are persistent colonizers. Rates of staphylococcal colonization
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are high among patients with diabetes, intravenous drug users, 
surgical patients and patients with the acquired 
immunodeficiency syndrome (2, 6). 
Even though in the last three decades pharmacological 
industries have produced a number of new antibiotics, the 
resistance to these drugs by microorganisms has increased. In 
general, bacteria have the genetic ability to transmit and 
acquire resistance to drugs which are utilized as therapeutic 
agents. New infections can occur in hospitals resulting in high 
mortality. Such a fact is cause for concern, because of the 
number of patients in hospitals who have suppressed immunity, 
and due to new bacterial strains which are multi-resistant (13).  
Methicillin-resistant Staphylococcus aureus (MRSA), 
identified in the early 1960s coincident with the introduction of 
methicillin, is now one of the most common causes of bacterial 
nosocomial infections, mainly in intensive care units. 
Methicillin resistance results from the production of an altered 
penicillin binding protein which has decreased affinity for most 
beta-lactam antibiotics (7, 24).   
Flavonoids are phenolic substances widely distributed in 
all vascular plants and increasingly are becoming the subject of 
medical research. They have been reported to possess many 
properties as anti-inflammatory (4), oestrogenic (11), enzyme 
inhibition (9), antimicrobial (10), antiallergic (8), antioxidant 
(23), vascular (22) and cytotoxic antitumor (3) activities, 
between others. Most of the beneficial health effects of 
flavonoids are attributed to their ability to inhibit lipid 
peroxidation, chelate redox-active metals, and attenuate other 
processes involving reactive oxygen species (12). Related 
studies of antimicrobial activity indicate that crude extracts 
containing flavonoids, triterpenes and steroids have showed 
significative activity against various strains of S. aureus (21). 
The combination of antibiotics with different modes of action 
against bacterial cells is useful for treatment of bacterial 
infections. Combination effects between flavonoids and 
antibiotics have also been reported. Thus, Shibata et al. (20) 
found that flavone and its derivatives have synergistic action 
with the ß-lactams, intensified the susceptibility in MRSA and 
MSSA.   Furthermore, the flavonoid synergistic activity against 
antibiotic resistant bacteria, under low concentration 
minimizing the possible toxic effects, was reported (1, 18, 19). 
The aim of the present work was to investigate in vitro 
synergism between several  chalcones substituted in 
combination with oxacillin, antibiotic used conventionally 
against S. aureus  43 300 (MRSA) which is resistant to it. 
Kinetic turbidimetric method developed earlier was employed 
(15). 
 
MATERIALS AND METHODS 
 
Compounds 
Oxacillin, sodium salt monohydrate (Sigma-Aldrich); 
2´,3-dihydroxychalcone (1), 2´,4-dihydroxychalcone (2), 2´,4´-
dihydroxychalcone (3) and 2´,4´,3-trihydroxychalcone (4) were 
all synthesized in our laboratory by Claisen-Schmidt 
condensation and identified by chromatographic and 
spectroscopic techniques (TLC, UV-Vis, IR, NMR) (5). In 
addition, 2´,4´-dihydroxy-3´-methoxychalcone (5), a natural 
compound isolated from Zuccagnia punctata Cav., a native 
plant to San Luis (Argentina) (17) was assayed. Figure 1 
illustrates the compound structures. Oxacillin and different 
chalcones solutions were prepared in absolute ethanol and 
diluted for antimicrobial assays. 
 
Bacterial strains 
Staphylococcus aureus ATCC 43 300 (MRSA) strain 
(purchased from American Type Culture Collection), 
maintained by successive subcultures in trypticase soy agar 
BBL (Becton Dickinson) at 4ºC and by lyophilization, was 
used. 
 
Cultura media 
Broth and agar nutritive and broth and agar Müller-Hinton 
(Oxoid) were used.  
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Kinetic-turbidimetric assays 
In order to determine quantitatively the sensitivity of S. 
aureus to oxacillin and its increase when oxacillin is used in 
combination with several chalcones, a previously developed 
kinetic-turbidimetric method was employed (15). 
A 24 h culture of S. aureus ATCC 43 300 in agar slant 
was transferred to 30 mL of Müller-Hinton broth and incubated 
at 35ºC for 18 h, with permanent stirring, in order to be used as 
inoculum. Kinetic experiments of microbial growth were 
performed in Erlenmeyer flasks containing 100 mL of Müller-
Hinton broth with addition of increasing concentrations of 
antibiotic oxacillin and 2 mL of previously prepared inoculum. 
Subsequently, Erlenmeyer flasks were incubated in a Rosi 
1000 culture chamber (35ºC, 180 rpm). Aliquots were 
extracted at 20 min intervals for 5 h and the transmittances 
were read at 720 nm. A flask without antibiotic was used as 
control. This first experiment enabled us to choose the optimal 
oxacillin concentration to be used in the next trials (6 µg.mL-1).  
For synergism determination, similar experiments in 
presence of chalcone in increasing concentrations, alone or in 
combination with oxacillin, were performed. 
In the following equation:  
                                            
     ln Nt = 27.4 – 10.3 . T                      (1) 
 
the transmittance (T) values at 720 nm were related to the 
number CFU/mL (Nt) (15). 
All trials were conducted in triplicate and standard 
deviations of the specific growth rate, were in all cases lower 
than 0.001. 
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Figure 1. Structure of compounds: 1: 2´,3- dihydroxychalcone; 2: 2´,4- dihydroxychalcone; 3: 2´,4´- dihydroxychalcone; 4: 
2´,4´,3- trihydroxychalcone; 5: 2´,4´-dihydroxy-3´-methoxychalcone.  
 
 
RESULTS AND DISCUSSION 
 
The number of CFU/mL at different times was obtained 
by the turbidimetric kinetic method (Eq. 1). The microbial 
growth can be expressed by the equation: 
            ln Nt = ln No + µ . t                                              (2) 
 
where t is time in min, No is CFU/mL at t = 0, Nt is CFU/mL at 
t = t and µ is specific growth rate (in min-1).  
Growth rates values in media with increasing chalcone 
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concentration and their combinations with oxacillin constant 
concentration were obtained from the exponential phase of ln 
Nt vs. t plots.  
Table 1 exhibits the specific growth rates of S. aureus 
obtained in presence of chalcones isolated and  chalcones - 
oxacillin combinations with the respective MIC values. 
 
Table 1. Specific growth rates and minimal inhibitory concentration for all systems assayed against a methicillin-resistant 
Staphylococcus aureus strain. 
Chalcone Concentration (µg.mL
-1) 
                                       0                    5.00                 10.0                   15.0                20.0  
MIC 
µg.mL-1 
µ (isolated) 0.0465 0.0380 0.0158 0.00130 0 15.8 1 
µ (comb) 0.0465 0.0231 0.00616 0 0 11.2 
µ (isolated) 0.0453 0.0389 0.0350 0.0314 0.0312 45.0 2 
µ (comb) 0.0453 0.0150 0.0115 0.0112 0.00653 22.4 
µ (isolated) 0.0476 0.0373 0.0247 0.00425 0.000400 20.1 
3 µ (comb) 0.0476 0.0296 0.00928 0.00343 0 15.3 
µ (isolated) 0.0459 0.0386 0.0314 0.0254 0.0131 30.8 4 
µ (comb) 0.0459 0.0279 0.0197 0.0157 0.00719 22.5 
µ (isolated) 0.0464 0.0391 0.0348 0.0292 0.0244 42.5 5 
µ (comb) 0.0464 0.00988 0.00866 0.00818 0.00766 ∞ 
1: 2´,3- dihydroxychalcone; 2: 2´,4- dihydroxychalcone; 3: 2´,4´- dihydroxychalcone; 4: 2´,4´,3- trihydroxychalcone; 5: 2´,4´-dihydroxy-3´-
methoxychalcone. MIC: minimal inhibitory concentration. 
 
       
The specific growth rate values decreasing when the 
experiment was made in presence of oxacillin constant 
concentration. This fact is observed in Table 1 for all assayed 
combinations. The results were satisfactory, except for 2´,4´-
dihydroxy-3´-methoxychalcone – oxacillin. 
They are in accordance with bacteriostatic inhibition 
mechanism previously proposed (15). In the same, the 
exponential growth law of microorganisms and the possible 
adsorption of substances on the cell wall were considered, 
resulting in the reduction or cancellation of some vital 
function: 
 
µT 
N   2N 
kI 
C+N    C-N 
 
The growth rate of bacteria by this mechanism is 
expressed as: 
 
dN/dt = µT . N – kI  . C. N        o       dN/dt = (µT – kI.C) N 
 
Comparing this relationship with the exponential growth 
law dN/dt = µ.N, it is inferred that: 
          
µ = µT – kI . C                                                         (3) 
 
where µT: specific growth rate without drug (min-1) (control), 
kI: specific inhibition rate (mL.µg-1.min-1) and C: drug 
concentration (µg.mL-1). The minimal inhibhitory 
concentration (MIC) was calculated by extrapolation at µ = 0 
from the graphical representation of equation 3.    
For 2´,4´-dihydroxy-3´-methoxychalcone – oxacillin 
combination, antagonist is observed, probably due to the strong 
complex formation between both molecules. This fact provokes 
a decrease of the chalcone bacteriostatic activity.      
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To facilitate comparison of the inhibitory action between 
structurally related substances such as chalcones and their 
combinations with conventional antibiotic oxacillin, should be 
determined the percentual bacteriostatic efficiency of a drug 
(PBE) (16), in the form: 
 
             PBE = 100/MIC                                                      (4)  
 
where MIC: minimum inhibitory concentration (µg.mL-1) and 
100: percentage arbitrary numerical factor. Evaluating 
chalcones PBE tested and comparing with the PBE of these 
chalcones with oxacillin, can be established that combinations 
PBE are higher, demonstrating synergism for all of them, 
except for 2´,4´,dihydroxy-4´-methoxychalcone – oxacillin 
combination (Table 2).   
Table 2. Minimal inhibitory concentration and percentual bacteriostatic efficiency of isolated chalcones and of chalcones-oxacillin 
combinations against a methicillin-resistant Staphylococcus aureus strain.    
Chalcone    MIC (comb)     PBE (isolated)                               PBE  (comb) 
1 11.2 
           6.33                              <                              8.93 
2 22.4 2.22 << 4.46 
3 15.3 4.97 << 6.53 
4 22.5 3.25 < 4.44 
5 73.9 2.35 >>> ≈ 0 
1: 2´,3- dihydroxychalcone; 2: 2´,4- dihydroxychalcone; 3: 2´,4´- dihydroxychalcone; 4: 2´,4´,3- trihydroxychalcone; 5: 2´,4´-
dihydroxy-3´-methoxychalcone. MIC: minimal inhibitory concentration. 
 
 
Chalcones activity against methicillin-resistant 
Staphylococcus aureus (MRSA) was detected by kinetic-
turbidimetric method. This inhibition was observed with the 
isolated chalcones and with their combinations with oxacillin, 
an  ineffective antibiotic. The chalcones – oxacillin 
combinations showed an interesting synergic action.  
Due to the growing problem of microbial resistant, the 
outlook for the use of antimicrobial drugs is uncertain. 
Consequently, the development of researches which seek to 
increase antibacterial activity and to characterize the 
interaction mechanism with antibiotics woud be desirable.        
Thus, the synergistic effect between chalcones and 
oxacillin is an important way that could lead to the 
development of new combination antibiotics against MRSA 
infections.  
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